Target intelligence / Profile preview

Long intergenic non-protein coding RNA 529 (LINC00529)

Target
LINC00529
Molecular classification
Long intergenic non-protein coding RNA (lincRNA), Long non-coding RNA (lncRNA)
01

Overview

LINC00529 is a non-coding RNA gene that produces long intergenic non-protein coding RNA 529. As a canonical lincRNA, it is transcribed from intergenic regions that do not overlap protein-coding genes and exceeds 200 nucleotides in length. LincRNAs, including LINC00529, play diverse roles in gene regulation, epigenetic modification, and chromatin structure, although the precise functional significance of LINC00529 in human biology is currently unknown. No protein products are encoded by LINC00529, and it is not conventionally considered a drug target, nor is it associated with any pharmacological interactions or safety concerns. While other lincRNAs may affect disease pathways, further research would be needed to elucidate the specific biological and clinical relevance of LINC00529. Key points: - Long intergenic non-protein coding RNA 529 (LINC00529) is a human lincRNA. - It is not a traditional therapeutic target, and no drugs interact with it. - No aliases, disease roles, biomarkers, or safety concerns are described in the literature for LINC00529. - Molecular classification: belongs to the long intergenic non-coding RNA family (lincRNAs), a subtype of long non-coding RNAs (lncRNAs). - Functions: general gene regulation and chromatin modulation, with no demonstrated specific activity attributed to LINC00529.

02

Biological functions

Gene regulation (often involved in *cis* or *trans* regulation of nearby or distant genes)Chromatin remodeling and transcriptional regulation (general)Although broad lincRNA functions include cell growth, division, and the cell cycle, specific biological roles for LINC00529 have not been characterized in the available data
03

Disease associations

Other (there is no disease association reported specifically for LINC00529; however, some lincRNAs are implicated as diagnostic markers or regulators in cancer and other diseases)LINC00529 itself is not yet linked to specific disease states or clinical utility as a biomarker

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 529 (LINC00529).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 529 (LINC00529).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call